Last reviewed · How we verify

XaraColl — Competitive Intelligence Brief

XaraColl (XaraColl) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Bioabsorbable hemostatic and antimicrobial wound matrix. Area: Surgery/Wound Management.

marketed Bioabsorbable hemostatic and antimicrobial wound matrix Chlorhexidine (broad-spectrum antimicrobial); collagen matrix (hemostatic scaffold) Surgery/Wound Management Small molecule Live · refreshed every 30 min

Target snapshot

XaraColl (XaraColl) — Innocoll. XaraColl is a bioabsorbable collagen matrix that delivers chlorhexidine locally to promote hemostasis and reduce infection in surgical wounds.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
XaraColl TARGET XaraColl Innocoll marketed Bioabsorbable hemostatic and antimicrobial wound matrix Chlorhexidine (broad-spectrum antimicrobial); collagen matrix (hemostatic scaffold)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Bioabsorbable hemostatic and antimicrobial wound matrix class)

  1. Innocoll · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). XaraColl — Competitive Intelligence Brief. https://druglandscape.com/ci/xaracoll. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: